Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Narrative) (Details)

v3.10.0.1
Related Party Transactions (Narrative) (Details) - Chief Scientific Officer [Member] - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Related Party Transaction [Line Items]    
Ownership interest 25.00%  
Aspen Park Pharmaceuticals, Inc. (APP) [Member]    
Related Party Transaction [Line Items]    
Related party transactions, amount $ 0 $ 375,000